Literature DB >> 20066281

Synthesis and glycosidase inhibitory activity of noeurostegine-a new and potent inhibitor of beta-glucoside hydrolases.

Tina Secher Rasmussen1, Henrik Helligsø Jensen.   

Abstract

A new, stable hemi-aminal nor-tropane christened noeurostegine was synthesised in 22 steps from levoglucosan and tested for inhibitory activity against glycoside hydrolases. Sweet almond and Thermotoga maritimabeta-glucosidases, coffee bean alpha-galactosidase, and Asp. oryzaebeta-galactosidase were inhibited in the low micromolar region but significant tightening of binding to K(i) 50 nM for almond beta-glucosidase was found to occur after pre-incubation. Yeast alpha-glucosidase and E. colibeta-galactosidase were not inhibited at 1 mM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20066281     DOI: 10.1039/b918576c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Stereospecific synthesis of methyl 2-amino-2-deoxy-(6S)-deuterio-α,β-d-glucopyranoside and methyl 2,6-diamino-2,6-dideoxy-(6R)-deuterio-α,β-d-glucopyranoside: Side chain conformations of the 2-amino-2-deoxy and 2,6-diamino-2,6-dideoxyglucopyranosides.

Authors:  Takayuki Kato; Andrea Vasella; David Crich
Journal:  Carbohydr Res       Date:  2017-05-19       Impact factor: 2.104

2.  Stereospecific synthesis of methyl 2-amino-2,4-dideoxy-6S-deuterio-α-D-xylo-hexopyranoside and methyl 2-amino-2,4-dideoxy-6S-deuterio-4-propyl-α-d-glucopyranoside: Side chain conformation of the novel aminoglycoside antibiotic propylamycin.

Authors:  Michael G Pirrone; Takahiko Matsushita; Andrea Vasella; David Crich
Journal:  Carbohydr Res       Date:  2020-03-16       Impact factor: 2.104

3.  The Bicyclic Form of galacto-Noeurostegine Is a Potent Inhibitor of β-Galactocerebrosidase.

Authors:  Agnete Viuff; Stéphane Salamone; Joseph McLoughlin; Janet E Deane; Henrik H Jensen
Journal:  ACS Med Chem Lett       Date:  2020-12-18       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.